1. Home
  2. FET vs SVRA Comparison

FET vs SVRA Comparison

Compare FET & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forum Energy Technologies Inc.

FET

Forum Energy Technologies Inc.

N/A

Current Price

$69.24

Market Cap

953.8M

Sector

Industrials

ML Signal

N/A

Logo Savara Inc.

SVRA

Savara Inc.

N/A

Current Price

$4.33

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FET
SVRA
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
953.8M
1.1B
IPO Year
2007
2009

Fundamental Metrics

Financial Performance
Metric
FET
SVRA
Price
$69.24
$4.33
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $11.06
AVG Volume (30 Days)
138.6K
★ 3.3M
Earning Date
10-29-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 92.64
N/A
EPS
★ 2.38
N/A
Revenue
★ $791,474,000.00
N/A
Revenue This Year
$15.23
N/A
Revenue Next Year
$7.08
$4,204.68
P/E Ratio
$30.27
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$29.77
$4.13
52 Week High
$91.99
$7.01

Technical Indicators

Market Signals
Indicator
FET
SVRA
Relative Strength Index (RSI) 37.63 43.06
Support Level $67.50 N/A
Resistance Level $85.27 $5.44
Average True Range (ATR) 4.04 0.36
MACD -0.48 -0.00
Stochastic Oscillator 11.82 26.49

Price Performance

Historical Comparison
FET
SVRA

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a manufacturing company serving the oil, natural gas, industrial, and renewable energy industries. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. The company operates in two reportable segments: Drilling and Completions, and Artificial Lift and Downhole. Maximum revenue is generated from the Drilling and Completions segment, which offers products used in the drilling process, and other products like hydraulic fracturing pumps, ROVs and trenchers, submarine rescue vehicles, etc. Geographically, the firm generates maximum revenue from the U.S., followed by Canada, Middle East, Europe and Africa, Asia-Pacific, and Latin America.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: